XML 44 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
12 Months Ended
Dec. 31, 2020
Income Taxes [Abstract]  
Income Taxes
17. Income Taxes

The income tax provision (benefit) consists of the following (in thousands):

 
 
Year Ended December 31,
 
 
 
2020
   
2019
   
2018
 
Current:
                 
Domestic
 
$
30,368
   
$
14,632
   
$
26,821
 
Foreign
   
4,064
     
3,019
     
3,180
 
Total current
   
34,432
     
17,651
     
30,001
 
 
                       
Deferred:
                       
Domestic
   
(7,418
)
   
4,677
     
(10,132
)
Foreign
   
(52
)
   
417
     
108
 
Total deferred
   
(7,470
)
   
5,094
     
(10,024
)
Total income tax provision
 
$
26,962
   
$
22,745
   
$
19,977
 

Reconciliations between taxes at the U.S. Federal income tax rate and taxes at our effective income tax rate on earnings from continuing operations before income taxes are as follows (in thousands):

 
 
Year Ended December 31,
 
 
 
2020
   
2019
   
2018
 
 
                 
U.S. Federal income tax rate of 21%
 
$
22,550
   
$
19,277
   
$
16,135
 
Increase (decrease) in tax rate resulting from:
                       
State and local income taxes, net of federal income tax benefit
   
3,781
     
3,328
     
2,781
 
Income tax (tax benefits) attributable to foreign income
   
330
     
191
     
1,598
 
Other non-deductible items, net
   
(563
)
   
(409
)
   
(559
)
Change in valuation allowance
   
864
     
358
     
22
 
Provision for income taxes
 
$
26,962
   
$
22,745
   
$
19,977
 

The following is a summary of the components of the net deferred tax assets and liabilities recognized in the accompanying consolidated balance sheets (in thousands):

 
 
December 31,
 
 
 
2020
   
2019
 
Deferred tax assets:
           
Inventories
 
$
12,773
   
$
12,077
 
Allowance for customer returns
   
13,804
     
11,969
 
Postretirement benefits
   
42
     
50
 
Allowance for doubtful accounts
   
1,412
     
1,262
 
Accrued salaries and benefits
   
12,984
     
9,826
 
Tax credit carryforwards
   
1,451
     
609
 
Accrued asbestos liabilities
   
15,372
     
13,132
 
Other
   
170
     
148
 
 
   
58,008
     
49,073
 
Valuation allowance
   
(1,621
)
   
(757
)
Total deferred tax assets
   
56,387
     
48,316
 
Deferred tax liabilities:
               
Depreciation
   
7,710
     
7,706
 
Other
   
3,907
     
3,338
 
Total deferred tax liabilities
   
11,617
     
11,044
 
 
               
Net deferred tax assets
 
$
44,770
   
$
37,272
 


In assessing the realizability of the deferred tax assets, we consider whether it is more likely than not that some portion or the entire deferred tax asset will be realized.  Ultimately, the realization of the deferred tax asset is dependent upon the generation of sufficient taxable income in those periods in which temporary differences become deductible and/or net operating loss carryforwards can be utilized.  We consider the level of historical taxable income, scheduled reversal of temporary differences, carryback and carryforward periods, tax planning strategies and projected future taxable income in determining whether a valuation allowance is warranted.  We also consider cumulative losses in recent years as well as the impact of one-time events in assessing our pre-tax earnings. Assumptions regarding future taxable income require significant judgment. Our assumptions are consistent with estimates and plans used to manage our business.

The valuation allowance of $1.6 million as of December 31, 2020 is intended to provide for uncertainty regarding the ultimate realization of our U.S. foreign tax credit carryovers and foreign net operating loss carryovers.  Based on these considerations, we believe it is more likely than not that we would realize the benefit of the net deferred tax asset of $44.8 million as of December 31, 2020, which is net of the remaining valuation allowance. At December 31, 2020, we have foreign tax credit carryforwards of approximately $1.5 million that will expire in varying amounts by 2028.

As related to the taxation of our foreign subsidiaries, we aggregate our foreign earnings and profits, and utilize allowable deductions and available foreign tax credits in computing our U.S. tax.  Notwithstanding the U.S. taxation of these amounts, we intend to continue to invest most or all of these earnings indefinitely outside of the U.S., and do not expect to incur any significant additional taxes related to such amounts.

In accordance with generally accepted accounting practices, we recognize in our financial statements only those tax positions that meet the more-likely-than-not recognition threshold.  We establish tax reserves for uncertain tax positions that do not meet this threshold.  During the years ended December 31, 2020, 2019 and 2018, we did not establish a liability for uncertain tax positions.

We are subject to taxation in the U.S. and various state, local and foreign jurisdictions.  As of December 31, 2020, the Company is no longer subject to U.S. Federal tax examinations for years before 2017.  We remain subject to examination by state and local tax authorities for tax years 2016 through 2019.  Foreign jurisdictions have statutes of limitations generally ranging from 2 to 6 years.  Years still open to examination by foreign tax authorities in major jurisdictions include Canada (2016 onward), Hong Kong (2015 onward), Mexico (2016 onward) and Poland (2015 onward).  We do not presently anticipate that our unrecognized tax benefits will significantly increase or decrease over the next 12 months; however, actual developments in this area could differ from those currently expected.